# The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers

> **NCT02833389** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 72 (actual)

## Conditions studied

- Neuropathic Diabetic Foot Ulcers

## Interventions

- **DRUG:** Placebo
- **DRUG:** UTTR1147A

## Key facts

- **NCT ID:** NCT02833389
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-14
- **Primary completion:** 2018-11-12
- **Final completion:** 2018-11-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2018-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02833389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02833389, "The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02833389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*